U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C12H14N2O2
Molecular Weight 218.2518
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FONTURACETAM

SMILES

NC(=O)CN1CC(CC1=O)C2=CC=CC=C2

InChI

InChIKey=LYONXVJRBWWGQO-UHFFFAOYSA-N
InChI=1S/C12H14N2O2/c13-11(15)8-14-7-10(6-12(14)16)9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,13,15)

HIDE SMILES / InChI
Molecular Formula C12H14N2O2
Molecular Weight 218.2518
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Fonturacetam, also known as Phenylpiracetam, is marketed in Russia as Carphedon and Phenotropil. It is one of the first ever nootropic drugs and originally discovered in Russia. Fonturacetam acts on most neurotransmitter systems and has been used for its cognitive and physical enhancing properties, and also as an antidepressant.

CNS Activity

CNS Active
3913
Curator's Comment: Acting as an antidepressant and memory enhancer in rat models.

Originator

Institute of medico-biological problems
1
Curator's Comment: The above link is the earliest reference available on Pubmed. There is an earlier reported synthesis which is not available online. Glozman, O. M.; Morozov, I. S.; Zhmurenko, L. A.; Zagorevskii, V. A. (1980). 'Synthesis and anticonvulsive activity of 4-phenyl-2-pyrrolidinone-1-acetic acid amides'. Khimiko-Farmatsevticheskii Zhurnal (in Russian). 14 (11): 43–48.

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Antagonist
2778
 5.8 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Not Provided
504
phenotropil

Approved Use

Approved in Russia as a nootropic. Phenotropil activates the integrative brain activity, consolidates memory, increases concentration and mental work, improves learning ability, increases the transmission of information between cerebral hemispheres, raises the resistance of brain tissues to hypoxia and poisonous actions. Has a positive effect on metabolism and blood circulation of the brain. It is used to treat metabolic and vascular cerebral disorders, mental function disorders, depression, obesity, convulsions. The stimulating effect of Phenotropil provides an improvement in physical performance, coordination, and stamina.
Primary
Not Provided
504
phenotropil

Approved Use

Approved in Russia as a nootropic. Phenotropil activates the integrative brain activity, consolidates memory, increases concentration and mental work, improves learning ability, increases the transmission of information between cerebral hemispheres, raises the resistance of brain tissues to hypoxia and poisonous actions. Has a positive effect on metabolism and blood circulation of the brain. It is used to treat metabolic and vascular cerebral disorders, mental function disorders, depression, obesity, convulsions. The stimulating effect of Phenotropil provides an improvement in physical performance, coordination, and stamina.
Primary
Not Provided
504
phenotropil

Approved Use

Approved in Russia as a nootropic. Phenotropil activates the integrative brain activity, consolidates memory, increases concentration and mental work, improves learning ability, increases the transmission of information between cerebral hemispheres, raises the resistance of brain tissues to hypoxia and poisonous actions. Has a positive effect on metabolism and blood circulation of the brain. It is used to treat metabolic and vascular cerebral disorders, mental function disorders, depression, obesity, convulsions. The stimulating effect of Phenotropil provides an improvement in physical performance, coordination, and stamina.
Primary
Not Provided
504
phenotropil

Approved Use

Approved in Russia as a nootropic. Phenotropil activates the integrative brain activity, consolidates memory, increases concentration and mental work, improves learning ability, increases the transmission of information between cerebral hemispheres, raises the resistance of brain tissues to hypoxia and poisonous actions. Has a positive effect on metabolism and blood circulation of the brain. It is used to treat metabolic and vascular cerebral disorders, mental function disorders, depression, obesity, convulsions. The stimulating effect of Phenotropil provides an improvement in physical performance, coordination, and stamina.
Primary
Not Provided
504
phenotropil

Approved Use

Approved in Russia as a nootropic. Phenotropil activates the integrative brain activity, consolidates memory, increases concentration and mental work, improves learning ability, increases the transmission of information between cerebral hemispheres, raises the resistance of brain tissues to hypoxia and poisonous actions. Has a positive effect on metabolism and blood circulation of the brain. It is used to treat metabolic and vascular cerebral disorders, mental function disorders, depression, obesity, convulsions. The stimulating effect of Phenotropil provides an improvement in physical performance, coordination, and stamina.
PubMed

PubMed

TitleDatePubMed
Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.
2010 Feb 12
Patents

Patents

0363489
1
2014005720
1
2014005721
1

Sample Use Guides

In Vivo Use Guide
A Russian manufacturer of Phenotropil recommends 100 mg per day.
Route of Administration: Oral
In Vitro Use Guide
In vitro, phenotropil (IC50 = 5.86 μM) directly influenced α4β2 nicotinic acetylcholine receptors in the mouse brain cortex.
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:15:33 GMT 2023
Edited
by admin
on Fri Dec 15 17:15:33 GMT 2023
Record UNII
99QW5JU66Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FONTURACETAM
INN   MART.  
INN  
Official Name English
(R,S)-2-(2-OXO-4-PHENYLPYRROLIDIN-1-YL)ACETAMIDE
Systematic Name English
RAC-2-((4R)-2-OXO-4-PHENYLPYROLIDIN-1-YL)ACETAMIDE
Common Name English
PHENYLPIRACETAM
Common Name English
4-Phenylpiracetam [WHO-DD]
Common Name English
fonturacetam [INN]
Common Name English
2-(2-OXO-4-PHENYL-PYRROLIDIN-1-YL)ACETAMIDE
Systematic Name English
CARPHEDON
Common Name English
PHENOTROPYL
Common Name English
FONTURACETAM [MART.]
Common Name English
CARPHEDONE
Common Name English
1-PYRROLIDINEACETAMIDE, 2-OXO-4-PHENYL-
Systematic Name English
4-PHENYLPIRACETAM
WHO-DD  
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1509
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
DSLD 4049 (Number of products:6)
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
Code System Code Type Description
INN
9111
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
PRIMARY
PUBCHEM
132441
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
PRIMARY
NCI_THESAURUS
C96852
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
PRIMARY
EPA CompTox
DTXSID30868438
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
FONTURACETAM
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
PRIMARY Phenylpiracetam is one of the most peculiar and stimulating nootropics currently available, it has effects very similar to stacking Adderall and piracetam. Due to its added Phenyl group, it influences dopamine receptors in the brain, and therefore carries much the same effect. It also targets memory, focus and overall brain health, phenylpiraceatm is bar none one of my favorite nootropics for these reasons, it is available in 90 capsules as well as a cheaper sampler pack version.
EVMPD
SUB126212
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
PRIMARY
SMS_ID
100000151722
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
PRIMARY
WIKIPEDIA
Phenylpiracetam
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
PRIMARY A small number of low-scale clinical studies have shown possible links between prescription of phenylpiracetam and improvement in a number of encephalopathic conditions, including lesions of cerebral blood pathways, traumatic brain injury and certain types of glioma. Phenylpiracetam reverses the depressant effects of the benzodiazepine diazepam, increases operant behavior, inhibits post-rotational nystagmus, prevents retrograde amnesia, and has anticonvulsant properties. Phenylpiracetam is typically prescribed as a general stimulant or to increase tolerance to extreme temperatures and stress.
FDA UNII
99QW5JU66Y
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
PRIMARY
CAS
77472-70-9
Created by admin on Fri Dec 15 17:15:33 GMT 2023 , Edited by admin on Fri Dec 15 17:15:33 GMT 2023
PRIMARY
Related Record Type Details
Structure of FONTURACETAM, (S)-
ENANTIOMER -> RACEMATE
Structure of FONTURACETAM, (R)-
ENANTIOMER -> RACEMATE
Related Record Type Details
Structure of FONTURACETAM
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966